PT103003A - Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids giving high zinc and nickel ion complexing capacity - Google Patents
Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids giving high zinc and nickel ion complexing capacityInfo
- Publication number
- PT103003A PT103003A PT103003A PT103003A PT103003A PT 103003 A PT103003 A PT 103003A PT 103003 A PT103003 A PT 103003A PT 103003 A PT103003 A PT 103003A PT 103003 A PT103003 A PT 103003A
- Authority
- PT
- Portugal
- Prior art keywords
- capacity
- ion complexing
- nickel ion
- inhibitors comprises
- metal enzyme
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids containing at least one hydroxamate group and functional groups or moelcular residues. The Zn (II) and Ni (II) ion complexing capacity is high, for inhibiting metalloproteinases (matrices and bacteria pharmacology).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT103003A PT103003A (en) | 2003-08-04 | 2003-08-04 | Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids giving high zinc and nickel ion complexing capacity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT103003A PT103003A (en) | 2003-08-04 | 2003-08-04 | Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids giving high zinc and nickel ion complexing capacity |
Publications (1)
Publication Number | Publication Date |
---|---|
PT103003A true PT103003A (en) | 2005-02-28 |
Family
ID=34836875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT103003A PT103003A (en) | 2003-08-04 | 2003-08-04 | Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids giving high zinc and nickel ion complexing capacity |
Country Status (1)
Country | Link |
---|---|
PT (1) | PT103003A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9700599B2 (en) | 2012-11-13 | 2017-07-11 | Adocia | Rapid-acting insulin formulation comprising a substituted anionic compound |
US9795678B2 (en) | 2014-05-14 | 2017-10-24 | Adocia | Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound |
US10525133B2 (en) | 2014-05-14 | 2020-01-07 | Adocia | Aqueous composition comprising at least one protein and one solubilizing agent, preparation thereof and uses thereof |
US10792335B2 (en) | 2015-11-16 | 2020-10-06 | Adocia | Rapid-acting insulin composition comprising a substituted citrate |
-
2003
- 2003-08-04 PT PT103003A patent/PT103003A/en active IP Right Grant
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9700599B2 (en) | 2012-11-13 | 2017-07-11 | Adocia | Rapid-acting insulin formulation comprising a substituted anionic compound |
US10583175B2 (en) | 2012-11-13 | 2020-03-10 | Adocia | Rapid-acting insulin formulation comprising a substituted anionic compound |
US10646551B2 (en) | 2012-11-13 | 2020-05-12 | Adocia | Rapid-acting insulin formulation comprising a substituted anionic compound |
US10881716B2 (en) | 2012-11-13 | 2021-01-05 | Adocia | Rapid-acting insulin formulation comprising a substituted anionic compound |
US11324808B2 (en) | 2012-11-13 | 2022-05-10 | Adocia | Rapid-acting insulin formulation comprising a substituted anionic compound |
US9795678B2 (en) | 2014-05-14 | 2017-10-24 | Adocia | Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound |
US10525133B2 (en) | 2014-05-14 | 2020-01-07 | Adocia | Aqueous composition comprising at least one protein and one solubilizing agent, preparation thereof and uses thereof |
US10792335B2 (en) | 2015-11-16 | 2020-10-06 | Adocia | Rapid-acting insulin composition comprising a substituted citrate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1983000A3 (en) | Method for the treatment of multiple sclerosis by inhibiting IL-17 activity | |
AU2964295A (en) | Inhibitors of leukocyte adhesion | |
WO2006040357A3 (en) | Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases | |
AU2001278157A1 (en) | Liquid composition | |
CA2397124A1 (en) | Method for disinfecting a dense fluid medium in a dense medium plasma reactor | |
IL109177A0 (en) | Inhibitor of stem cell proliferation and uses thereof | |
WO2004043374A3 (en) | Methods and compositions for treating cancer using proteasome inhibitors | |
MX2009006227A (en) | Aspartyl protease inhibitors containing a tricyclic ring system. | |
IN2006KO01346A (en) | ||
MY117948A (en) | Nitride oxide synthase inhibitors. | |
HK1156515A1 (en) | Pharmaceutical compositions and methods for accelerating wound healing | |
AU2002363250A1 (en) | Pyrazole-amides and-sulfonamides | |
WO2004047879A3 (en) | Antimicrobial lenses, processes to prepare them and methods of their use | |
SI1805211T1 (en) | Purification of glycopeptides | |
HK1108701A1 (en) | Inhibitor of stem cell proliferation and uses thereof | |
EP0813544A4 (en) | ||
AU2003238386A1 (en) | Electrode for gas evolution and method for its production | |
AU2003223913A1 (en) | Agents for treating less thanigreater thanflaviviridaeless than/igreater than infections | |
WO2004087073A3 (en) | Treatment of demyelinating conditions | |
PT103003A (en) | Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids giving high zinc and nickel ion complexing capacity | |
TW200608893A (en) | An iron sequestering antimicrobial composition | |
IL165259A (en) | Compounds useful in the treatment of anthrax and inhibiting lethal factor | |
UA91057C2 (en) | An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating b cell neoplasm | |
WO2004084799A3 (en) | Pharmaceutical compositions for inhibiting metal ion dependent enzymatic activity and methods for the use thereof | |
EP1222925A3 (en) | Kavalactone as TNF-alpha production inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 20040129 |
|
FG3A | Patent granted, date of granting |
Effective date: 20050804 |